L****8
发帖数: 1203 | 1 INSYS Therapeutics, Inc., a development stage company, develops
pharmaceutical products that target the unmet needs of cancer patients, with
a focus on cancer-supportive care. The company’s cancer-supportive care
and cancer therapy product candidates include Fentanyl sublingual spray, a
single-use product for the treatment of breakthrough cancer pain; and
Dronabinol SG capsule, an ANDA approved product and Dronabinol Oral Solution
, which completed Phase II clinical trials for the treatment of chemotherapy
-induced nausea and vomiting, and appetite stimulation in AIDS patients. It
also develops proprietary cancer therapeutics comprising LEP-ETU, a NeoLipid
liposomal, which is in Phase II clinical development stage to enhance
efficacy and reduce paclitaxel-related side effects. The company was founded
in 2002 and is based in Phoenix, Arizona. | L****8
发帖数: 1203 | 2 7/1/2011 0.3 /shares
with
Solution
chemotherapy
It
NeoLipid
【在 L****8 的大作中提到】
: INSYS Therapeutics, Inc., a development stage company, develops
: pharmaceutical products that target the unmet needs of cancer patients, with
: a focus on cancer-supportive care. The company’s cancer-supportive care
: and cancer therapy product candidates include Fentanyl sublingual spray, a
: single-use product for the treatment of breakthrough cancer pain; and
: Dronabinol SG capsule, an ANDA approved product and Dronabinol Oral Solution
: , which completed Phase II clinical trials for the treatment of chemotherapy
: -induced nausea and vomiting, and appetite stimulation in AIDS patients. It
: also develops proprietary cancer therapeutics comprising LEP-ETU, a NeoLipid
: liposomal, which is in Phase II clinical development stage to enhance
|
|
